[CLDX] YoY Quarter Result on 30-Jun-2015 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
10-Aug-2015
Financial Year
2015
Quarter
30-Jun-2015 [#Q2]
Profit Trend
QoQ- -7.24%
YoY- -14.45%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 2,763 3,829 1,389 2,178 592 97 2,009 5.45%
PBT -16,407 -28,566 -31,952 -32,359 -28,274 -19,016 -13,362 3.47%
Tax -15,798 1,276 -828 -782 -275 -161 -252 99.24%
NP -16,407 -28,566 -31,952 -32,359 -28,274 -19,016 -13,773 2.95%
Tax Rate - - - - - - - -
Total Cost 19,170 32,395 33,341 34,537 28,866 19,113 15,782 3.29%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin -593.81 -746.04 -2,300.36 -1,485.72 -4,776.01 -19,604.12 -685.56 -2.36%
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
EPS -1.67 -3.42 -4.85 -4.93 -4.75 -3.53 -3.52 -11.68%
EPS Diluted -1.67 -3.42 -4.85 -4.93 -4.75 -3.53 -3.52 -11.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.